Khang & Khang LLP Investigating KV Pharmaceutical Company On Behalf of Shareholders
LOS ANGELES, Nov. 26, 2008 (GLOBE NEWSWIRE) -- Khang & Khang LLP today announced it is investigating potential claims against KV Pharmaceutical Company ("KV Pharmaceutical" or the "Company")(NYSE:KV-A) (NYSE:KV-B) concerning possible securities violations arising from public statements made by the Company between February 15, 2008 and November 12, 2008. The investigation pertains to allegations that certain public statements made by the Company during that period failed to disclose, among other things, violations of Food and Drug Administration regulations and other compliance matters and management misconduct.Filed by admin at November 26th, 2008 under News